JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2976
Rambus
RMBS
$12.2B
| $2.79M | ﹤0.01% |
195,920
+181,383
| +1,248% | +$2.61M |
2016 Q4
4 quarters
|
|
|
HSII
2977
DELISTED
Heidrick & Struggles
HSII
| $2.78M | ﹤0.01% |
113,203
+17,588
| +18% | +$412K |
2013 Q2
18 quarters
|
|
2978
Compañía de Minas Buenaventura
BVN
$7.95B
| $2.77M | ﹤0.01% |
197,116
-105,959
| -35% | -$1.47M |
2013 Q2
18 quarters
|
|
|
MAGN
2979
Magnera Corp
MAGN
$415M
| $2.77M | ﹤0.01% |
9,948
+864
| +10% | +$225K |
2013 Q2
18 quarters
|
|
|
IMGN
2980
DELISTED
Immunogen Inc
IMGN
| $2.77M | ﹤0.01% |
432,662
+431,871
| +54,598% | +$2.66M |
2016 Q4
4 quarters
|
|
2981
Globus Medical
GMED
$10.2B
| $2.77M | ﹤0.01% |
67,430
+65,896
| +4,296% | +$2.31M |
2015 Q4
8 quarters
|
|
2982
CALL
Kroger
KR
$34.8B
| $2.76M | ﹤0.01% |
100,700
+75,700
| +303% | +$1.76M |
2017 Q2
2 quarters
|
|
2983
Employers Holdings
EIG
$880M
| $2.76M | ﹤0.01% |
62,161
+33,519
| +117% | +$1.58M |
2016 Q2
6 quarters
|
|
2984
PUT
Kohl's
KSS
$2.15B
| $2.76M | ﹤0.01% |
50,900
-89,100
| -64% | -$4.1M |
2017 Q3
1 quarter
|
|
2985
Badger Meter
BMI
$3.74B
| $2.75M | ﹤0.01% |
57,452
+40,555
| +240% | +$1.88M |
2015 Q4
8 quarters
|
|
|
FINV
2986
FinVolution Group
FINV
$692M
| $2.74M | ﹤0.01% |
+385,851
| New | +$3.51M |
2017 Q4
0 quarters
|
|
2987
PUT
Fastenal
FAST
$58.1B
| $2.73M | ﹤0.01% |
+200,000
| New | +$2.48M |
2017 Q4
0 quarters
|
|
2988
OceanFirst Financial
OCFC
$1.62B
| $2.73M | ﹤0.01% |
104,070
+5,913
| +6% | +$161K |
2013 Q2
18 quarters
|
|
2989
Wolfspeed
WOLF
$1.87B
| $2.73M | ﹤0.01% |
73,414
+58,648
| +397% | +$2.02M |
2017 Q1
3 quarters
|
|
|
FLG
2990
Flagstar Bank National Association
FLG
$4.89B
| $2.73M | ﹤0.01% |
69,808
+66,708
| +2,152% | +$2.58M |
2013 Q2
18 quarters
|
|
2991
Zurn Elkay Water Solutions
ZWS
$7.97B
| $2.73M | ﹤0.01% |
217,442
+47,316
| +28% | +$571K |
2013 Q2
18 quarters
|
|
2992
CALL
PPG Industries
PPG
$23.4B
| $2.72M | ﹤0.01% |
23,300
+1,000
| +4% | +$115K |
2017 Q3
1 quarter
|
|
|
MRLN
2993
DELISTED
Marlin Business Services Corp
MRLN
| $2.72M | ﹤0.01% |
121,317
-20,920
| -15% | -$519K |
2013 Q2
18 quarters
|
|
2994
Ichor Holdings
ICHR
$2.36B
| $2.69M | ﹤0.01% |
109,475
+1,075
| +1% | +$30.5K |
2017 Q3
1 quarter
|
|
2995
PUT
Tractor Supply
TSCO
$16.3B
| $2.69M | ﹤0.01% |
+180,000
| New | +$2.31M |
2017 Q4
0 quarters
|
|
2996
Vanguard FTSE All-World ex-US ETF
VEU
$68.7B
| $2.69M | ﹤0.01% |
49,136
-143,104
| -74% | -$7.7M |
2013 Q2
18 quarters
|
|
2997
Wingstop
WING
$2.9B
| $2.69M | ﹤0.01% |
68,949
+67,944
| +6,761% | +$2.5M |
2016 Q4
4 quarters
|
|
2998
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.39B
| $2.68M | ﹤0.01% |
73,335
+58,458
| +393% | +$2.07M |
2016 Q4
4 quarters
|
|
|
IO
2999
DELISTED
ION Geophysical Corporation
IO
| $2.67M | ﹤0.01% |
135,293
+16,734
| +14% | +$210K |
2016 Q1
7 quarters
|
|
3000
PUT
PTC Therapeutics
PTCT
$5.27B
| $2.67M | ﹤0.01% |
+160,000
| New | +$2.71M |
2017 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.